中文 | English
Return
Total: 1613 , 1/162
Show Home Prev Next End page: GO
Author:( Lu, YE)

1.Challenges and common sense of PS≥2 patients with non-small cell lung cancer

Xiangyun YE ; Shun LU

Cancer Research and Clinic 2000;0(01):-

2.Advances in the targeted therapy of cancer:multi-targeted Raf kinase inhibitor

Jiade LU ; Ye GUO

China Oncology 1998;0(01):-

3.Enlightenment of Drug Pricing and Drug Administration Policy in UK

Lu YE ; Shanlian HU

China Pharmacy 2001;0(09):-

4.Effects of Automobil Exhausts on Immune Adherence Function of Erythrocytes in Mice

Jie XING ; Lu YE

Journal of Environment and Health 1992;0(02):-

5.Pricing Policy on Patent Drugs in Sweden and Its Implication for China

Ruixue WU ; Lu YE

China Pharmacy 1991;0(01):-

6.Review on Pricing Policy of Patent Drugs in UK

Ruixue WU ; Lu YE

China Pharmacy 2001;0(07):-

7.Comparison of the effects of propofol combined with remifentanil in different ratios for intravenous anesthesia

Xiaoya YE ; Bingquan LU

Chinese Journal of Primary Medicine and Pharmacy 2011;18(4):500-502

8.Regulation of platelet endogenous reactive oxygen species on platelet hyperreactivity

Kaichuang YE ; Xinwu LU

International Journal of Surgery 2008;35(10):684-686

9.Advance in the impact of mesenchymal stem cells on tumor growth

Ye DING ; Hua LU

Journal of Leukemia & Lymphoma 2008;17(5):398-400

10.Seed cells used in cellular cardiomyoplasty

Jiaxin YE ; Xinzheng LU

Chinese Journal of Tissue Engineering Research 2007;0(38):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1613 , 1/162 Show Home Prev Next End page: GO